Daiwa Securities Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-64
Closed -$1K 1304
2020
Q4
$1K Sell
64
-128
-67% -$2K ﹤0.01% 1247
2020
Q3
$2K Hold
192
﹤0.01% 1144
2020
Q2
$2K Hold
192
﹤0.01% 1158
2020
Q1
$2K Hold
192
﹤0.01% 1165
2019
Q4
$3K Buy
+192
New +$3K ﹤0.01% 1141